Brassard et al analyzed a Canadian database cohort of >427,000 people and, finding 564 cases of tuberculosis, announced that users of inhaled corticosteroids had a rate ratio of ~1.26 to 1.97 over never-users, with current and high-dose ICS users on the higher end of that range.